Zhang Wei-ying, Xu Fu-qing, Shan Chang-liang, Xiang Rong, Ye Li-hong, Zhang Xiao-dong
Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, Institute for Molecular Biology, College of Life Sciences, Nankai University, Tianjin, China.
Acta Pharmacol Sin. 2009 Apr;30(4):424-34. doi: 10.1038/aps.2009.22.
To demonstrate the gene expression profiles mediated by hepatitis B virus X protein (HBx), we characterized the molecular features of pathogenesis associated with HBx in a human liver cell model.
We examined gene expression profiles in L-O2-X cells, an engineered L-O2 cell line that constitutively expresses HBx, relative to L-O2 cells using an Agilent 22 K human 70-mer oligonucleotide microarray representing more than 21,329 unique, well-characterized Homo sapiens genes. Western blot analysis and RNA interference (RNAi) targeting HBx mRNA validated the overexpression of proliferating cell nuclear antigen (PCNA) and Bcl-2 in L-O2-X cells. Meanwhile, the BrdU incorporation assay was used to test cell proliferation mediated by upregulated cyclooxygenase-2 (COX-2).
The microarray showed that the expression levels of 152 genes were remarkably altered; 82 of the genes were upregulated and 70 genes were downregulated in L-O2-X cells. The altered genes were associated with signal transduction pathways, cell cycle, metastasis, transcriptional regulation, immune response, metabolism, and other processes. PCNA and Bcl-2 were upregulated in L-O2-X cells. Furthermore, we found that COX-2 upregulation in L-O2-X cells enhanced proliferation using the BrdU incorporation assay, whereas indomethacin (an inhibitor of COX-2) abolished the promotion.
Our findings provide new evidence that HBx is able to regulate many genes that may be involved in the carcinogenesis. These regulated genes mediated by HBx may serve as molecular targets for the prevention and treatment of hepatocellular carcinoma.
为了展示由乙型肝炎病毒X蛋白(HBx)介导的基因表达谱,我们在人肝细胞模型中对与HBx相关的发病机制的分子特征进行了表征。
我们使用代表超过21,329个独特的、特征明确的智人基因的安捷伦22 K人类70聚体寡核苷酸微阵列,检测了L-O2-X细胞(一种组成性表达HBx的工程化L-O2细胞系)相对于L-O2细胞的基因表达谱。针对HBx mRNA的蛋白质印迹分析和RNA干扰(RNAi)验证了增殖细胞核抗原(PCNA)和Bcl-2在L-O2-X细胞中的过表达。同时,使用BrdU掺入试验来测试由上调的环氧化酶-2(COX-2)介导的细胞增殖。
微阵列显示152个基因的表达水平发生了显著改变;在L-O2-X细胞中,82个基因上调,70个基因下调。这些改变的基因与信号转导通路、细胞周期、转移、转录调控、免疫反应、代谢和其他过程相关。PCNA和Bcl-2在L-O2-X细胞中上调。此外,我们发现使用BrdU掺入试验,L-O2-X细胞中COX-2的上调增强了增殖,而吲哚美辛(一种COX-2抑制剂)消除了这种促进作用。
我们的研究结果提供了新的证据,表明HBx能够调节许多可能参与致癌作用的基因。这些由HBx调节的基因可能作为预防和治疗肝细胞癌的分子靶点。